NCT02118077View on ClinicalTrials.gov

Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

April 30, 2004

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

G17DT

Sponsors
All Listed Sponsors
lead

Cancer Advances Inc.

INDUSTRY

NCT02118077 - Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter